Mid-term follow-up in patients with diaphragmatic plication after surgery for congenital heart disease

Julia Lemmer1, Brigitte Stiller, Grit Heise

  • 1Department of Congenital Heart Disease, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. lemmer@dhzb.de

Insights

Diaphragmatic palsy (DP) after heart surgery significantly reduces lung function and exercise capacity. Diaphragmatic plication is a safe treatment for children with respiratory issues, showing no mid-term risks.

Area of Science:

  • Pediatric Cardiology
  • Thoracic Surgery
  • Pulmonology

Background:

  • Diaphragmatic palsy (DP) is a severe complication following congenital heart surgery.
  • Transthoracic diaphragmatic plication is used to treat respiratory impairment from DP.
  • Mid-term outcomes of diaphragmatic plication are not well-established.

Purpose of the Study:

  • To evaluate the mid-term effects of diaphragmatic plication in patients with post-surgical DP.
  • To assess lung function and exercise capacity in patients with DP compared to controls.

Main Methods:

  • Ultrasound assessment of diaphragm movement in 24 patients with a history of DP.
  • Lung function and exercise testing in DP patients (when age-appropriate) and a control group.
  • Comparison of outcomes between patients with and without diaphragmatic plication.

Main Results:

  • Paralyzed diaphragms remained largely static post-plication in most cases.
  • DP patients exhibited significantly reduced lung function (VC, FEV1) and exercise capacity (peak VO2) versus controls.
  • No significant differences in exercise capacity were observed between plicated and non-plicated DP patients; a trend towards lower lung function in plicated patients was noted.

Conclusions:

  • DP is a serious complication impacting mid-term lung function and exercise capacity.
  • Diaphragmatic plication appears to be a safe mid-term treatment for pediatric respiratory impairment due to DP.
  • Plication does not negatively affect phrenic nerve recovery, lung function, or exercise capacity in the mid-term.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...